Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.2400
+0.0150 (6.67%)
May 21, 2026, 1:55 PM EST
Microbix Biosystems Market Cap
Microbix Biosystems has a market cap or net worth of CAD 33.06 million as of May 21, 2026. Its market cap has decreased by -32.92% in one year.
Market Cap
33.06M
Enterprise Value
31.73M
Revenue
14.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
Market Cap Chart
Since October 1, 1992, Microbix Biosystems's market cap has increased from 13.38M to 33.06M, an increase of 147.08%. That is a compound annual growth rate of 2.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 33.06M | 3.43% |
| Dec 31, 2025 | 31.97M | -41.99% |
| Dec 31, 2024 | 55.10M | 3.47% |
| Dec 29, 2023 | 53.25M | -6.55% |
| Dec 30, 2022 | 56.99M | -47.62% |
| Dec 31, 2021 | 108.80M | 135.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 60.75M |
| Sernova Biotherapeutics | 58.44M |
| Quantum BioPharma | 54.10M |
| Medicenna Therapeutics | 45.05M |
| Lobe Sciences | 41.19M |
| MedMira | 38.60M |
| Defence Therapeutics | 35.62M |
| Devonian Health Group | 31.01M |